Concord Drugs Limited (BOM:538965)

Concord Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	962	311	352	256	254	254
Market Cap Growth	150.07%	-11.63%	37.54%	0.84%	-0.17%	146.63%
Enterprise Value	1,150	501	521	428	362	351
Last Close Price	73.00	31.08	35.17	27.45	29.00	29.05
PE Ratio	126.21	92.45	74.47	25.95	15.91	7.74
PS Ratio	2.13	0.69	0.78	0.49	0.43	0.49
PB Ratio	2.79	0.91	1.04	0.81	0.89	0.95
P/TBV Ratio	2.79	0.91	1.04	0.81	0.89	0.95
P/FCF Ratio	22.75	22.37	-	31.71	-	-
P/OCF Ratio	14.98	8.35	44.39	15.38	32.75	1567937.89
EV/Sales Ratio	2.55	1.11	1.16	0.82	0.61	0.68
EV/EBITDA Ratio	25.31	12.12	12.88	9.36	6.37	10.63
EV/EBIT Ratio	37.25	18.54	20.93	14.52	9.24	18.11
EV/FCF Ratio	27.19	36.08	-	53.05	-	-
Debt / Equity Ratio	0.56	0.56	0.52	0.54	0.58	0.49
Debt / EBITDA Ratio	4.22	4.65	4.33	3.71	2.89	3.92
Debt / FCF Ratio	4.53	13.85	-	21.04	-	-
Asset Turnover	0.64	0.73	0.77	0.91	1.11	0.95
Inventory Turnover	1.42	1.48	1.57	2.22	2.90	3.07
Quick Ratio	0.59	0.53	0.61	0.74	0.97	1.28
Current Ratio	1.55	1.56	1.79	2.01	1.77	2.22
Return on Equity (ROE)	1.69%	0.99%	1.44%	3.28%	5.78%	13.06%
Return on Assets (ROA)	2.72%	2.73%	2.66%	3.21%	4.60%	2.25%
Return on Invested Capital (ROIC)	3.29%	2.52%	3.75%	4.98%	6.58%	4.08%
Return on Capital Employed (ROCE)	7.90%	6.90%	6.60%	8.00%	11.90%	5.80%
Earnings Yield	0.60%	1.08%	1.34%	3.85%	6.29%	12.92%
FCF Yield	4.40%	4.47%	-0.64%	3.15%	-6.63%	-14.46%
Buyback Yield / Dilution	4.27%	-	-7.35%	-6.53%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.